Today: 17 June 2026
T1 Energy Shares Edge Lower Before Shareholder Vote on KORE Power Bid
16 June 2026
2 mins read

T1 Energy Shares Edge Lower Before Shareholder Vote on KORE Power Bid

New York, June 16, 2026, 16:20 EDT

  • T1 Energy ended the session at $8.63, slipping roughly 3.3%. The stock ranged from $8.27 to $8.99.
  • Shareholders plan to vote Wednesday on a proposal that would raise authorized common stock to 1 billion shares, doubling the current amount.
  • The KORE Power deal and G2_Austin funding needs are keeping dilution risk and execution concerns front and center for the company.

T1 Energy Inc. shares dropped Tuesday. The solar and battery supply-chain firm lost ground heading into the close, ahead of Wednesday’s shareholder vote on raising its authorized common stock.

Shares on the New York Stock Exchange closed at $8.625, off 29.5 cents, or 3.3%. The stock touched a high of $8.99 and dropped to $8.27. Volume was around 31.6 million shares.

T1’s annual meeting comes up Wednesday at noon Eastern, with online voting set to end at 11:59 p.m. Eastern on Tuesday. One of the items on the ballot would take authorized common shares to 1 billion from 500 million if approved. That could let the company issue more stock, but holders could end up with a smaller percentage if new shares go out, raising dilution concerns.

T1 is moving ahead with plans to buy KORE Power, which makes battery energy storage systems and software, in a deal valuing KORE at about $32 million. Battery energy storage systems, or BESS, hold power to use later, and are tied to grids and data centers. The company expects the deal to wrap up in the second quarter, pending typical conditions and a nod from KORE shareholders.

KORE will get part of its payment in T1 common stock, according to a June 8 filing. That includes about $9.6 million at closing, possible equity earn-outs, and maybe more shares depending on a receivable. The share count will use a 10-day volume-weighted average price.

T1 Chairman and CEO Dan Barcelo said this month that the company is “excited to welcome the NRI team to T1.” KORE Power CEO Jay Bellows said the deal could give customers what he called a “one-stop solution for generation, storage, system design, and ongoing operations.” T1 Energy Inc.

Investors are eyeing the funding of G2_Austin, T1’s solar cell plant now in the works. T1 said in May the first phase, 2.1 gigawatts, was moving forward as planned. First cell output is set for the fourth quarter of 2026. The company also said it still needs about $225 million to cover the rest of the Phase 1 budget after boosting a convertible-note sale. These notes can be swapped for shares under certain terms.

Barcelo said in the T1 results for May that the company was working on “hitting key construction milestones” and “targeting a comprehensive financing package” for G2_Austin. T1 posted $3.9 million in net income from continuing operations and $9.1 million of adjusted EBITDA for the first quarter. Net loss to common stockholders came to $21.4 million. EBITDA, or earnings before interest, tax, depreciation and amortization, leaves out some expenses. T1 Energy Inc.

The wider solar sector struggled too. First Solar slid roughly 3.3%. Canadian Solar lost around 1.2%. T1’s drop kept pace with the losses in some U.S.-listed solar names.

But the risks here are tied to the company. T1 said its risks to investors are building on schedule and budget, raising enough money, concentrated suppliers, tariffs, tax credit rules, and getting the KORE deal done. If the share authorization vote doesn’t go well, financing costs go up or G2_Austin gets delayed, the recent run in the stock could meet tougher headwinds.

A technology and finance expert writing for TS2.tech. He analyzes developments in satellites, telecommunications, and artificial intelligence, with a focus on their impact on global markets. Author of industry reports and market commentary, often cited in tech and business media. Passionate about innovation and the digital economy.

Stock Market Today

  • Coffee Prices Surge to 5-Week Highs on Brazil Rain Delays and Supply Concerns
    June 16, 2026, 6:44 PM EDT. Coffee prices reached 5-week highs on Tuesday, with Arabica up 5.44% and Robusta rising 1.72%, driven by heavy rain forecasts in Brazil risking harvest delays. Brazil, the world's largest coffee producer, faces persistent rainfall across its coffee regions, supported by a forecast for moderate to heavy rain from Vaisala. ICE Arabica inventories fell to a 6.75-month low, reinforcing supply tightness. Meanwhile, concerns mount over a potential El Niño event, projected to be one of the strongest on record, threatening Brazil's 2026/27 coffee crop with delayed rains during critical flowering months. Despite a USDA forecast of a record 2026/27 Brazil coffee crop of 71.9 million bags, supply risks and tighter shipping conditions caused by the Strait of Hormuz closure bolster prices. Vietnam's rising coffee exports create pressure on Robusta prices, but supply challenges persist for global coffee markets.

Latest articles

Aditxt trades near $0.01 with ADTX filings and Nasdaq delisting risk in focus

Aditxt trades near $0.01 with ADTX filings and Nasdaq delisting risk in focus

17 June 2026
Aditxt shares plunged 17% to $0.0109 amid nearly 929 million shares traded, as Nasdaq delisting risk and uncertainty over the $150 million Ignite Proteomics spin-off overshadowed HRT Financial’s purchase of 4.25 million shares at $0.016; the stock’s fate hinges on compliance and the Ignite deal’s completion.
Sadot Group drops 63% as Nasdaq deadline, deal filings shake investors

Sadot Group drops 63% as Nasdaq deadline, deal filings shake investors

17 June 2026
Sadot Group shares plunged 63.1% to $8.67 after a late-session volatility pause as investors weighed a looming June 22 Nasdaq delisting deadline tied to a stockholders’ equity shortfall, a $125.5 million Los Angeles property option paid with 17.71% of its stock, and ongoing liquidity and default risks.
Pfizer trades up with Rigel’s Veppanu deal done

Pfizer trades up with Rigel’s Veppanu deal done

17 June 2026
Pfizer shares edged up 0.15% to $26.04 after Rigel closed a Veppanu licensing deal with Arvinas and Pfizer, triggering a $35 million payment to Pfizer; the deal highlights ongoing investor focus on whether Pfizer’s oncology and obesity pipeline can offset COVID declines and looming patent losses, with analysts split on pipeline potential versus slow growth and patent pressure.
Rocket Companies steady at $14 as BTIG downgrades, firm refinances debt
Previous Story

Rocket Companies steady at $14 as BTIG downgrades, firm refinances debt

SRx Health Solutions gains as EMJX crypto pivot draws traders
Next Story

SRx Health Solutions gains as EMJX crypto pivot draws traders

Go toTop